Biological basis for novel mesothelioma therapies. (2021)
Attributed to:
Targeting PPP1R15 in malignancy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41416-021-01462-2
PubMed Identifier: 34226685
Publication URI: http://europepmc.org/abstract/MED/34226685
Type: Journal Article/Review
Volume: 125
Parent Publication: British journal of cancer
Issue: 8
ISSN: 0007-0920